Drugs / BBI-2000
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03089775 | Mar → May 2017 | contact dermatitis | Fresh Tracks Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BBI-2000 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03089775 ↗ |
| Route | Topical | “topically applied BBI-2000 (5%)” NCT03089775 ↗ |